Literature DB >> 6108158

Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats.

J D Yager, R Yager.   

Abstract

Entities:  

Keywords:  Animals, Laboratory; Biology; Cancer; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Diseases; Family Planning; Hepatic Effects; Laboratory Procedures; Mestranol; Neoplasms; Norethynodrel; Oral Contraceptives--side effects; Physiology; Research Methodology

Mesh：

Substances：

Year:  1980        PMID： 6108158

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  36 in total

Review 1.  Long-term adjuvant tamoxifen therapy for breast cancer.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1990-05       Impact factor: 4.872

2.  Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways.

Authors:  Lizao Chen; Jianming Zheng; Yan Zhang; Luxi Yang; Jiaqi Wang; Jian Ni; Daxiang Cui; Chaoqin Yu; Zailong Cai
Journal:  Mol Ther       Date:  2011-05-24       Impact factor: 11.454

3.  Age-dependent sensitivity of Big Blue transgenic mice to the mutagenicity of N-ethyl-N-nitrosourea (ENU) in liver.

Authors:  Nan Mei; Robert H Heflich; Martha M Moore; Tao Chen
Journal:  Mutat Res       Date:  2005-05-02       Impact factor: 2.433

4.  Abnormal sex-steroid milieu in young adults with hepatocellular carcinoma.

Authors:  R A Malt; J J Galdabini; B W Jeppsson
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

5.  Hepatocellular alterations after intraportal transplantation of ovarian tissue in ovariectomized rats.

Authors:  L Klotz; H J Hacker; D Klingmüller; P Bannasch; U Pfeifer; F Dombrowski
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

6.  Estrogen receptors in hepatocellular carcinoma: is endocrine therapy for hepatocellular carcinoma likely to be effective?

Authors:  K Kohigashi; Y Fukuda; H Imura
Journal:  Gastroenterol Jpn       Date:  1987-06

7.  Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma.

Authors:  Woon-Puay Koh; Jian-Min Yuan; Renwei Wang; Sugantha Govindarajan; Rowena Oppenheimer; Zhen Quan Zhang; Mimi C Yu; Sue Ann Ingles
Journal:  Cancer       Date:  2011-02-11       Impact factor: 6.860

8.  Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis.

Authors:  R Sato; C Maesawa; K Fujisawa; K Wada; K Oikawa; Y Takikawa; K Suzuki; H Oikawa; K Ishikawa; T Masuda
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

9.  Oral contraceptives and primary liver cancer among young women.

Authors:  A W Hsing; R N Hoover; J K McLaughlin; H T Co-Chien; S Wacholder; W J Blot; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

10.  Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma.

Authors:  F Farinati; N De Maria; A Fornasiero; M Salvagnini; S Fagiuoli; M Chiaramonte; R Naccarato
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.